Literature DB >> 26994221

Transient Surface CCR5 Expression by Naive CD8+ T Cells within Inflamed Lymph Nodes Is Dependent on High Endothelial Venule Interaction and Augments Th Cell-Dependent Memory Response.

David Askew1, Charles A Su2, Deborah S Barkauskas3, R Dixon Dorand4, Jay Myers3, Rachel Liou3, Joseph Nthale3, Alex Y Huang5.   

Abstract

In inflamed lymph nodes, Ag-specific CD4(+) and CD8(+) T cells encounter Ag-bearing dendritic cells and, together, this complex enhances the release of CCL3 and CCL4, which facilitate additional interaction with naive CD8(+) T cells. Although blocking CCL3 and CCL4 has no effect on primary CD8(+) T cell responses, it dramatically impairs the development of memory CD8(+) T cells upon Ag rechallenge. Despite the absence of detectable surface CCR5 expression on circulating native CD8(+) T cells, these data imply that naive CD8(+) T cells are capable of expressing surface CCR5 prior to cognate Ag-induced TCR signaling in inflamed lymph nodes; however, the molecular mechanisms have not been characterized to date. In this study, we show that CCR5, the receptor for CCL3 and CCL4, can be transiently upregulated on a subset of naive CD8(+) T cells and that this upregulation is dependent on direct contact with the high endothelial venule in inflamed lymph node. Binding of CD62L and CD11a on T cells to their ligands CD34 and CD54 on the high endothelial venule can be enhanced during inflammation. This enhanced binding and subsequent signaling promote the translocation of CCR5 molecules from intracellular vesicles to the surface of the CD8(+) T cell. The upregulation of CCR5 on the surface of the CD8(+) T cells increases the number of contacts with Ag-bearing dendritic cells, which ultimately results in increased CD8(+) T cell response to Ag rechallenge.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26994221      PMCID: PMC4868656          DOI: 10.4049/jimmunol.1501176

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes.

Authors:  Xingfeng Bao; E Ashley Moseman; Hideo Saito; Bronislawa Petryniak; Bronislawa Petryanik; Aude Thiriot; Shingo Hatakeyama; Yuki Ito; Hiroto Kawashima; Yu Yamaguchi; John B Lowe; Ulrich H von Andrian; Minoru Fukuda
Journal:  Immunity       Date:  2010-11-24       Impact factor: 31.745

Review 2.  Integrins in immunity.

Authors:  Rachel Evans; Irene Patzak; Lena Svensson; Katia De Filippo; Kristian Jones; Alison McDowall; Nancy Hogg
Journal:  J Cell Sci       Date:  2009-01-15       Impact factor: 5.285

3.  Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells.

Authors:  Kathrin Schumann; Tim Lämmermann; Markus Bruckner; Daniel F Legler; Julien Polleux; Joachim P Spatz; Gerold Schuler; Reinhold Förster; Manfred B Lutz; Lydia Sorokin; Michael Sixt
Journal:  Immunity       Date:  2010-05-13       Impact factor: 31.745

4.  Evidence for internal stores of CCR5 in blood cells.

Authors:  Hamasseh Shirvani; Lamia Achour; Mark G H Scott; Alain Thuret; Catherine Labbé-Jullié; Georges Bismuth; Stefano Marullo
Journal:  Blood       Date:  2011-07-28       Impact factor: 22.113

5.  Quantification of lymph node transit times reveals differences in antigen surveillance strategies of naive CD4+ and CD8+ T cells.

Authors:  Judith N Mandl; Rachel Liou; Frederick Klauschen; Nienke Vrisekoop; João P Monteiro; Andrew J Yates; Alex Y Huang; Ronald N Germain
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

6.  ICAM-1-dependent tuning of memory CD8 T-cell responses following acute infection.

Authors:  Maureen A Cox; Scott R Barnum; Daniel C Bullard; Allan J Zajac
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

7.  Central memory CD8+ T cells appear to have a shorter lifespan and reduced abundance as a function of HIV disease progression.

Authors:  Kristin Ladell; Marc K Hellerstein; Denise Cesar; Robert Busch; Drina Boban; Joseph M McCune
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

8.  CD4-CCR5 interaction in intracellular compartments contributes to receptor expression at the cell surface.

Authors:  Lamia Achour; Mark G H Scott; Hamasseh Shirvani; Alain Thuret; Georges Bismuth; Catherine Labbé-Jullié; Stefano Marullo
Journal:  Blood       Date:  2008-12-08       Impact factor: 22.113

9.  CD103 or LFA-1 engagement at the immune synapse between cytotoxic T cells and tumor cells promotes maturation and regulates T-cell effector functions.

Authors:  Katarzyna Franciszkiewicz; Audrey Le Floc'h; Marie Boutet; Isabelle Vergnon; Alain Schmitt; Fathia Mami-Chouaib
Journal:  Cancer Res       Date:  2012-11-27       Impact factor: 12.701

10.  Molecular mechanisms of lymphocyte homing to peripheral lymph nodes.

Authors:  R A Warnock; S Askari; E C Butcher; U H von Andrian
Journal:  J Exp Med       Date:  1998-01-19       Impact factor: 14.307

View more
  6 in total

Review 1.  Information flow in the spatiotemporal organization of immune responses.

Authors:  Jessica Y Huang; Miranda R Lyons-Cohen; Michael Y Gerner
Journal:  Immunol Rev       Date:  2021-11-29       Impact factor: 12.988

2.  CCL3 augments tumor rejection and enhances CD8+ T cell infiltration through NK and CD103+ dendritic cell recruitment via IFNγ.

Authors:  Frederick Allen; Iuliana D Bobanga; Peter Rauhe; Deborah Barkauskas; Nathan Teich; Caryn Tong; Jay Myers; Alex Y Huang
Journal:  Oncoimmunology       Date:  2017-11-20       Impact factor: 8.110

3.  Impacts of CCL4 gene polymorphisms on hepatocellular carcinoma susceptibility and development.

Authors:  Bin Wang; Ying-Erh Chou; Ming-Yu Lien; Chen-Ming Su; Shun-Fa Yang; Chih-Hsin Tang
Journal:  Int J Med Sci       Date:  2017-07-19       Impact factor: 3.738

4.  CCR5 Inhibitors and HIV-1 Infection.

Authors:  Olga S Latinovic; Marvin Reitz; Alonso Heredia
Journal:  J AIDS HIV Treat       Date:  2019

5.  FoxP3+ CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation.

Authors:  Alexis Yero; Tao Shi; Jean-Pierre Routy; Cécile Tremblay; Madeleine Durand; Cecilia T Costiniuk; Mohammad-Ali Jenabian
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

6.  CCL3 Enhances Antitumor Immune Priming in the Lymph Node via IFNγ with Dependency on Natural Killer Cells.

Authors:  Frederick Allen; Peter Rauhe; David Askew; Alexander A Tong; Joseph Nthale; Saada Eid; Jay T Myers; Caryn Tong; Alex Y Huang
Journal:  Front Immunol       Date:  2017-10-23       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.